Your browser doesn't support javascript.
loading
Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
Dong, L M; Zhang, X Y; Teng, H; Li, M S; Wang, P.
Affiliation
  • Dong LM; Department of Urological Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
  • Zhang XY; Department of Urological Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
  • Teng H; Department of Neurosurgery, The Shengjing Affiliated Hospital of China Medical University, Shenyang, China.
  • Li MS; Department of Emergency Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
  • Wang P; Department of Urological Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, China cmu4h_wp@126.com.
Genet Mol Res ; 13(4): 9976-85, 2014 Nov 28.
Article in En | MEDLINE | ID: mdl-25501209
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Genetic Predisposition to Disease / Polymorphism, Single Nucleotide / DNA-Binding Proteins / Genetic Association Studies Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Genetic Predisposition to Disease / Polymorphism, Single Nucleotide / DNA-Binding Proteins / Genetic Association Studies Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Year: 2014 Type: Article